Embryo Stem Cell Research: Ten Years of Controversy

  title={Embryo Stem Cell Research: Ten Years of Controversy},
  author={John A. Robertson},
  journal={The Journal of Law, Medicine \& Ethics},
  pages={191 - 203}
  • J. Robertson
  • Published 1 June 2010
  • Biology
  • The Journal of Law, Medicine & Ethics
Embryonic stem cell (ESC) research has been a source of ethical, legal, and social controversy since the first successful culturing of human ESCs in the laboratory in 1998. The controversy has slowed the pace of stem cell science and shaped many aspects of its subsequent development. This paper assesses the main issues that have bedeviled stem cell progress and identifies the ethical fault lines that are likely to continue. The time is appropriate for such an assessment because the field is… 

Stem Cell Research-Ethico-Legal Perspectives: Protection of Human Embryos

The Article studies the latest development in medical sciences is the use of Stem Cell therapy, which claims that stored stem cells can cure Seventy life-threatening diseases including diabetics, leukaemia, blood cancer, and Alzheimer’s diseases.

Induced Pluripotent Stem Cells: An Alternative to Embryonic Stem Cells?

It is argued that a new approach is needed to deal with the serious uncertainties and indeterminate probabilities intrinsic to stem cell research and decision-making surrounding it and it is concluded that in the current state of knowledge, stem cellResearch needs to continue and be allowed to unfold as the narrative of a story.

What Can We Say About Embryonic Stem Cell Researches from Ethical Point of View?

  • Mukadder GünB. Arda
  • Biology, Medicine
    Turkiye Klinikleri Journal of Medical Ethics-Law and History
  • 2020
Basic ethical topics such as the usage opportunities of human embryonic stem cell, regulations developed by various countries regarding the application of these techniques and violation of patient rights, informed consent, accessibility to treatment due to expensiveness, and making it trading are emphasized.

Pluripotent Stem Cells: The Search for the "Perfect" Source

Anyone who dreamed that the public controversy over human embryonic stem cell (hESC) research had begun to die down was rudely awakened by the decision in Sherley v. Sebelius.1 On August 23, District

Will Cell Reprogramming Resolve the Embryonic Stem Cell Controversy? A Narrative Review

It is argued that induced pluripotent stem cells are more ethically problematic than most people believe and that cell reprogramming will not solve the stem cell controversy but complicate it further.

Stem Cell Policy Exceptionalism: Proceed with Caution

It is suggested many of the issues identified by commentators may be addressed through the application of established policy frameworks governing the use of tissue, human stem cells, and research participation by human research subjects.

The Pluripotency Proposition: A Biological and Ethical Case for the Utilization of hiPSCs in Place of hESCs

A new type of human stem cell with the same type of potential as hESCs was created in 2007, and hiPSCs are generated without the destruction of a human embryo, and thus avoid the ethical controversy associated with hESC.


With the advent of advanced medical technologies, physicians can provide more thorough treatment than in years past. One of the burgeoning areas of research is regenerative medicine. This discipline

Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions

  • J. Banja
  • Medicine
    PM & R : the journal of injury, function, and rehabilitation
  • 2015



Creating Embryos for Use in Stem Cell Research

  • D. Brock
  • Biology
    Journal of Law, Medicine & Ethics
  • 2010
An issue that has had relatively little explicit and separate attention, but is likely to loom larger in light of the Obama administration's partial lifting of the Bush administration's restriction on the embryos that can be used in stem cell research that receives federal funding, is focused on.

Future Directions for Oversight of Stem Cell Research in the United States

Barack Obama entered this highly charged territory when he indicated during his campaign that once in office he would issue an executive order expanding federally funded human embryonic stem cell research and introduce rigorous oversight of it and without regard to the date of their derivation.

A Proposed Stem Cell Research Policy

A rule of public policy providing for the use of donated embryos barred from the womb is proposed, suitable for implementation by any government that funds hESC research and its justification provides a cogent argument for such incremental steps toward its implementation as become politically feasible from time to time.

Embryo Culture and the 'Culture of Life': Constitutional Issues in the Embryonic Stem Cell Debate

The "culture of life" debate has been a powerful force in recent American law and politics, particularly in end of life and reproductive settings. It has also played a major role in limiting federal

Political Interventions in U.S. Human Embryo Research: An Ethical Assessment

  • R. Green
  • Political Science
    Journal of Law, Medicine & Ethics
  • 2010
Although the first human embryonic stem cells (hESCs) were produced in 1998, the direction of U.S. policy on stem cell research was set nearly 20 years earlier when the recommendations of a

Allowing Innovative Stem Cell-Based Therapies outside of Clinical Trials: Ethical and Policy Challenges

  • I. Hyun
  • Biology, Medicine
    Journal of Law, Medicine & Ethics
  • 2010
Armed with expanded federal funding for human embryonic stem cell research and new methods for deriving pluripotent stem cells, stem cell researchers in the U.S. are poised to proceed with

Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease

Several clinical trials are now being carried out with stem cells derived from pluripotent cells, and many more can be expected in light of the rapid scientific progress in the field.

Issues in Oocyte Donation for Stem Cell Research

The informed consent process for donors should not minimize the risks of oocyte procurement just because the donors are not giving their oocytes for reproductive purposes, or portray stem cell transplantation research as an existing therapy.

Clinical trials in stem cell transplantation: guidelines for scientific and ethical review

These recommendations will help guarantee that the efficacy and safety of innovative stem cell interventions will be rigorously established, while also protecting study participants.

Embryonic Histrionics: A Critical Evaluation of the Bush Stem Cell Funding Policy and the Congressional Alternative

For the past decade, the debate over federal funding of human embryonic stem cell (hESC) research has dominated the national discussion of biomedical science policy. In 2001, President Bush announced